These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


226 related items for PubMed ID: 2857418

  • 1. Increased expression of HLA ABC class I antigens by muscle fibres in Duchenne muscular dystrophy, inflammatory myopathy, and other neuromuscular disorders.
    Appleyard ST, Dunn MJ, Dubowitz V, Rose ML.
    Lancet; 1985 Feb 16; 1(8425):361-3. PubMed ID: 2857418
    [Abstract] [Full Text] [Related]

  • 2. Expression of class I and class II MHC antigens in neuromuscular diseases.
    McDouall RM, Dunn MJ, Dubowitz V.
    J Neurol Sci; 1989 Feb 16; 89(2-3):213-26. PubMed ID: 2926449
    [Abstract] [Full Text] [Related]

  • 3. Skeletal muscle expression of class II histocompatibility antigens (HLA-DR) in polymyositis and other muscle disorders with an inflammatory infiltrate.
    Zuk JA, Fletcher A.
    J Clin Pathol; 1988 Apr 16; 41(4):410-4. PubMed ID: 3366926
    [Abstract] [Full Text] [Related]

  • 4. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells.
    Arahata K, Engel AG.
    Ann Neurol; 1984 Aug 16; 16(2):193-208. PubMed ID: 6383191
    [Abstract] [Full Text] [Related]

  • 5. HLA-A & HLA-B antigens in multiple sclerosis, motor neuron disease & Duchenne muscular dystrophy.
    Mehta MM, Chablani UA, Contractor NM, Bhatia HM, Singhal BS, Mondkar VP, Desai AD.
    Indian J Med Res; 1986 May 16; 83():519-21. PubMed ID: 3733208
    [No Abstract] [Full Text] [Related]

  • 6. Monoclonal antibodies to human leucocyte antigens in polymyositis and muscular dystrophy.
    Rowe D, Isenberg DA, Beverley PC.
    Clin Exp Immunol; 1983 Nov 16; 54(2):327-36. PubMed ID: 6228350
    [Abstract] [Full Text] [Related]

  • 7. Immunocytochemical localisation of complement components C8 and C9 in human diseased muscle. The role of complement in muscle fibre damage.
    Sewry CA, Dubowitz V, Abraha A, Luzio JP, Campbell AK.
    J Neurol Sci; 1987 Nov 16; 81(2-3):141-53. PubMed ID: 3694223
    [Abstract] [Full Text] [Related]

  • 8. Origin and significance of small muscle fibres in neuromuscular disease.
    Tang LM, Swash M.
    Virchows Arch A Pathol Anat Histopathol; 1986 Nov 16; 410(2):113-8. PubMed ID: 2948318
    [Abstract] [Full Text] [Related]

  • 9. Localization of interferons and interleukin 2 in polymyositis and muscular dystrophy.
    Isenberg DA, Rowe D, Shearer M, Novick D, Beverley PC.
    Clin Exp Immunol; 1986 Feb 16; 63(2):450-8. PubMed ID: 2421951
    [Abstract] [Full Text] [Related]

  • 10. Vacuolar myositis with expression of both MHC class I and class II antigens on skeletal muscle fibers.
    Higuchi I, Nerenberg M, Ijichi T, Fukunaga H, Arimura K, Usuki F, Kuriyama M, Osame M.
    J Neurol Sci; 1991 Nov 16; 106(1):60-6. PubMed ID: 1779240
    [Abstract] [Full Text] [Related]

  • 11. Inflammatory changes in affected muscles of facioscapulohumeral dystrophy.
    Honda H, Mano Y, Takahashi A.
    J Neurol; 1987 Aug 16; 234(6):408-11. PubMed ID: 3655843
    [Abstract] [Full Text] [Related]

  • 12. Nerve growth factor receptor immunoreactivity on the tunica adventitia of intramuscular blood vessels in childhood muscular dystrophies.
    Zhao J, Yoshioka K, Miike T, Kageshita T, Arao T.
    Neuromuscul Disord; 1991 Aug 16; 1(2):135-41. PubMed ID: 1668370
    [Abstract] [Full Text] [Related]

  • 13. Damage and inflammation in muscular dystrophy: potential implications and relationships with autoimmune myositis.
    Tidball JG, Wehling-Henricks M.
    Curr Opin Rheumatol; 2005 Nov 16; 17(6):707-13. PubMed ID: 16224247
    [Abstract] [Full Text] [Related]

  • 14. Possible neurogenic factor in muscular dystrophy: its similarity to denervation atrophy.
    Dastur DK, Razzak ZA.
    J Neurol Neurosurg Psychiatry; 1973 Jun 16; 36(3):399-410. PubMed ID: 4714102
    [Abstract] [Full Text] [Related]

  • 15. Unexpected sarcolemmal complement membrane attack complex deposits on nonnecrotic muscle fibers in muscular dystrophies.
    Spuler S, Engel AG.
    Neurology; 1998 Jan 16; 50(1):41-6. PubMed ID: 9443455
    [Abstract] [Full Text] [Related]

  • 16. Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies.
    Emslie-Smith AM, Arahata K, Engel AG.
    Hum Pathol; 1989 Mar 16; 20(3):224-31. PubMed ID: 2470663
    [Abstract] [Full Text] [Related]

  • 17. Immunolocalization of ubiquitin in muscle biopsies of patients with inclusion body myositis and oculopharyngeal muscular dystrophy.
    Askanas V, Serdaroglu P, Engel WK, Alvarez RB.
    Neurosci Lett; 1991 Sep 02; 130(1):73-6. PubMed ID: 1660975
    [Abstract] [Full Text] [Related]

  • 18. Ubiquitin and beta-amyloid-protein in inclusion body myositis (IBM), familial IBM-like disorder and oculopharyngeal muscular dystrophy: an immunocytochemical study.
    Leclerc A, Tomé FM, Fardeau M.
    Neuromuscul Disord; 1993 Jul 02; 3(4):283-91. PubMed ID: 8268725
    [Abstract] [Full Text] [Related]

  • 19. Human muscle cells express a functional costimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and in inflammatory lesions.
    Behrens L, Kerschensteiner M, Misgeld T, Goebels N, Wekerle H, Hohlfeld R.
    J Immunol; 1998 Dec 01; 161(11):5943-51. PubMed ID: 9834075
    [Abstract] [Full Text] [Related]

  • 20. Tenascin-C expression correlates with macrophage invasion in Duchenne muscular dystrophy and in myositis.
    Gullberg D, Velling T, Sjöberg G, Salmivirta K, Gaggero B, Tiger CF, Edström L, Sejersen T.
    Neuromuscul Disord; 1997 Jan 01; 7(1):39-54. PubMed ID: 9132139
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.